These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30371212)

  • 1. Small Molecule Derived From Carboxyethylpyrrole Protein Adducts Promotes Angiogenesis in a Mouse Model of Peripheral Arterial Disease.
    Hou L; Yang G; Tang S; Alcazar C; Joshi P; Strassberg Z; Kim M; Kawamura M; Woo YJ; Shrager J; Ding S; Huang NF
    J Am Heart Assoc; 2018 Sep; 7(18):e009234. PubMed ID: 30371212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth.
    Wu C; Wang X; Tomko N; Zhu J; Wang WR; Zhu J; Wangf B; Wang Y; Salomon RG
    Anticancer Agents Med Chem; 2017; 17(6):813-820. PubMed ID: 27671308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease.
    Rufaihah AJ; Huang NF; Jamé S; Lee JC; Nguyen HN; Byers B; De A; Okogbaa J; Rollins M; Reijo-Pera R; Gambhir SS; Cooke JP
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):e72-9. PubMed ID: 21836062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of involvement of CEP adducts in TLR activation and in angiogenesis.
    Gounarides J; Cobb JS; Zhou J; Cook F; Yang X; Yin H; Meredith E; Rao C; Huang Q; Xu Y; Anderson K; De Erkenez A; Liao SM; Crowley M; Buchanan N; Poor S; Qiu Y; Fassbender E; Shen S; Woolfenden A; Jensen A; Cepeda R; Etemad-Gilbertson B; Giza S; Mogi M; Jaffee B; Azarian S
    PLoS One; 2014; 9(10):e111472. PubMed ID: 25343517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands.
    West XZ; Malinin NL; Merkulova AA; Tischenko M; Kerr BA; Borden EC; Podrez EA; Salomon RG; Byzova TV
    Nature; 2010 Oct; 467(7318):972-6. PubMed ID: 20927103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-vascular endothelial growth factor treatment induces blood flow recovery through vascular remodeling in high-fat diet induced diabetic mice.
    Xiao L; Yan K; Yang Y; Chen N; Li Y; Deng X; Wang L; Liu Y; Mu L; Li R; Luo M; Ren M; Wu J
    Microvasc Res; 2016 May; 105():70-6. PubMed ID: 26808210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.
    Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM
    Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic angiogenesis in a murine model of limb ischemia by recombinant periostin and its fasciclin I domain.
    Kim BR; Jang IH; Shin SH; Kwon YW; Heo SC; Choi EJ; Lee JS; Kim JH
    Biochim Biophys Acta; 2014 Sep; 1842(9):1324-32. PubMed ID: 24834847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
    Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
    J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties.
    Smadja DM; d'Audigier C; Bièche I; Evrard S; Mauge L; Dias JV; Labreuche J; Laurendeau I; Marsac B; Dizier B; Wagner-Ballon O; Boisson-Vidal C; Morandi V; Duong-Van-Huyen JP; Bruneval P; Dignat-George F; Emmerich J; Gaussem P
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):551-9. PubMed ID: 21148423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells.
    Hardy B; Battler A; Weiss C; Kudasi O; Raiter A
    Biochem Pharmacol; 2008 Feb; 75(4):891-9. PubMed ID: 18022603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passive exercise using whole-body periodic acceleration enhances blood supply to ischemic hindlimb.
    Rokutanda T; Izumiya Y; Miura M; Fukuda S; Shimada K; Izumi Y; Nakamura Y; Araki S; Hanatani S; Matsubara J; Nakamura T; Kataoka K; Yasuda O; Kaikita K; Sugiyama S; Kim-Mitsuyama S; Yoshikawa J; Fujita M; Yoshiyama M; Ogawa H
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2872-80. PubMed ID: 21940947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat extract promotes angiogenesis in a murine model of limb ischemia: a novel cell-free therapeutic strategy.
    Yu Z; Cai Y; Deng M; Li D; Wang X; Zheng H; Xu Y; Li W; Zhang W
    Stem Cell Res Ther; 2018 Nov; 9(1):294. PubMed ID: 30409190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice.
    Nakano M; Satoh K; Fukumoto Y; Ito Y; Kagaya Y; Ishii N; Sugamura K; Shimokawa H
    Circ Res; 2007 Mar; 100(5):662-9. PubMed ID: 17293480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
    Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
    Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic effects of adrenomedullin in ischemia and tumor growth.
    Iimuro S; Shindo T; Moriyama N; Amaki T; Niu P; Takeda N; Iwata H; Zhang Y; Ebihara A; Nagai R
    Circ Res; 2004 Aug; 95(4):415-23. PubMed ID: 15242974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
    Ganta VC; Choi M; Kutateladze A; Annex BH
    Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model.
    Albrecht-Schgoer K; Barthelmes J; Schgoer W; Theurl M; Nardin I; Lener D; Gutmann C; Dünnhaupt S; Bernkop-Schnürch A; Kirchmair R
    J Control Release; 2017 Mar; 250():1-8. PubMed ID: 28167285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.